Dr. Angie G. Nishio Lucar, MD

Dr. Nishio Lucar practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Nishio Lucar's NPI, 1891986485, was assigned on August 7, 2007. Dr. Nishio Lucar holds Virginia license 0101253840.

Dr. Nishio Lucar's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Nishio Lucar's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Nishio Lucar is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Nishio Lucar to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nishio Lucar practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nishio Lucar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Nishio Lucar is licensed in Virginia.

CMS data shows 647 Medicare services from Dr. Nishio Lucar across 4 procedure codes in 2024, for 165 Medicare patients. Medicare paid $51,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Nishio Lucar in 2024. The largest group is under 65, with 80 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 4.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nishio Lucar's median patient age at 55, with 39% women.

In 2024, Dr. Nishio Lucar wrote 1,793 Medicare Part D claims for 170 patients. 90% of them were for generic drugs. CMS names the drug for 1,565 of them, across 32 drugs with 11 or more claims each, at $255,220 in total drug cost. In 2023, CMS named 1,505 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Nishio Lucar for performance year 2024, reported as part of a group. Dr. Nishio Lucar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nishio Lucar as offering telehealth.

Dmand AI links 7 papers to Dr. Nishio Lucar, published from 2018 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Living Donors and Tissue and Organ Procurement. Dr. Nishio Lucar has published most often in Transpl Infect Dis. Dr. Nishio Lucar's most frequent co-authors are Mona Devang Doshi, MD, Vineeta Kumar and Beatrice L. Concepcion, MD.

CMS Open Payments shows 4 general payments to Dr. Nishio Lucar from 3 drug and device companies from 2018 to 2025. Education make up the largest share, 51% of the total. Alexion Pharmaceuticals, Inc. paid the most, $185.